Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Angewandte Chemie (International Ed. in English)|November 30, 2016
Decarboxylative [4+2] Cycloaddition by Synergistic Palladium and OrganocatalysisLars A Leth, Florian Glaus, Marta Meazza, et al.Regulatory Toxicology and Pharmacology : RTP|July 6, 2010
Evaluation of inhalation TTC values with the database RepDoseS E Escher, I Tluczkiewicz, M Batke, et al.Arthritis and Rheumatism|August 18, 2001
Effects of low-dose, noncytotoxic, intraarticular liposomal clodronate on development of erosions and proteoglycan loss in established antigen-induced arthritis in rabbitsA Ceponis, E Waris, J Mönkkönen, et al.Journal of Neuroimmunology|February 1, 1996
Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosisP Rieckmann, F Weber, A Günther, et al.Journal of Neuroimmunology|November 26, 2002
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1bJ Brettschneider, D Ecker, A Bitsch, et al.European Journal of Neurology|June 14, 2008
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patientsA Millonig, A Dressel, D Bahner, et al.Acta Neurologica Scandinavica|November 6, 2004
Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosisA Bitsch, D Bahner, C Wachter, et al.Journal of Neuroimmunology|February 13, 2001
Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosisH Hackstein, A Bitsch, A Bohnert, et al.Environmental Science. Processes & Impacts|February 3, 2018
Development of a novel scoring system for identifying emerging chemical risks in the food chainJ Oltmanns, O Licht, A Bitsch, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2005
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating diseaseS J Pittock, R L McClelland, S J Achenbach, et al.Pageof 6